Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Clifford A. Hudis

Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update

Journal of Clinical Oncology

English

Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-Per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)

Journal of Clinical Oncology

English

MONARCH 1, a Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients With Refractory HR + /HER2 − Metastatic Breast Cancer

Clinical Cancer Research

Cancer Research

Oncology

2017

English

Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology

Journal of the National Comprehensive Cancer Network : JNCCN

Medicine

Oncology

2016

English

Bridging the Gap Among Clinical Practice Guidelines for Pain Management in Cancer and Sickle Cell Disease

Journal of the National Comprehensive Cancer Network : JNCCN

Medicine

Oncology

2020

English

Real Transparency in Medicine: Time to Act

English

Triple-Negative Breast Cancer: An Unmet Medical Need

English

Estrogen and HER-2 Receptor Discordance Between Primary Breast Cancer and Metastasis

English

Noninvasive Detection of Inflammatory Changes in White Adipose Tissue by Label-Free Raman Spectroscopy

Analytical Chemistry

2016

English

Axillary Management of Stage II/III Breast Cancer in Patients Treated With Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative)

Journal of the American College of Surgeons

Surgery

2017

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Clifford A. Hudis

Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update

Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-Per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)

MONARCH 1, a Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients With Refractory HR + /HER2 − Metastatic Breast Cancer

Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology

Bridging the Gap Among Clinical Practice Guidelines for Pain Management in Cancer and Sickle Cell Disease

Real Transparency in Medicine: Time to Act

Triple-Negative Breast Cancer: An Unmet Medical Need

Estrogen and HER-2 Receptor Discordance Between Primary Breast Cancer and Metastasis

Noninvasive Detection of Inflammatory Changes in White Adipose Tissue by Label-Free Raman Spectroscopy

Axillary Management of Stage II/III Breast Cancer in Patients Treated With Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative)